BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong L, Wang W, Li A, Kansal R, Chen Y, Chen H, Li X. Clinical Next Generation Sequencing for Precision Medicine in Cancer. Curr Genomics 2015;16:253-63. [PMID: 27006629 DOI: 10.2174/1389202915666150511205313] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Mortlock A, Wilson D, Kettle J, Goldberg F, Foote K. Selective Kinase Inhibitors in Cancer. Comprehensive Medicinal Chemistry III. Elsevier; 2017. pp. 39-75. [DOI: 10.1016/b978-0-12-409547-2.12391-1] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Thomford NE, Dzobo K, Chimusa E, Andrae-marobela K, Chirikure S, Wonkam A, Dandara C. Personalized Herbal Medicine? A Roadmap for Convergence of Herbal and Precision Medicine Biomarker Innovations. OMICS: A Journal of Integrative Biology 2018;22:375-91. [DOI: 10.1089/omi.2018.0074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
3 Giardina T, Robinson C, Grieu-iacopetta F, Millward M, Iacopetta B, Spagnolo D, Amanuel B. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice. Pathology 2018;50:389-401. [DOI: 10.1016/j.pathol.2018.01.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
4 Shylasree TS, Richa B, Lavanya G, Gulia S. Molecular Signatures of Gynecological Cancers: Clinicians Perspective. Indian J Surg Oncol 2021;12:103-10. [PMID: 33994735 DOI: 10.1007/s13193-020-01271-8] [Reference Citation Analysis]
5 Anis E, Hawkins IK, Ilha MRS, Woldemeskel MW, Saliki JT, Wilkes RP. Evaluation of Targeted Next-Generation Sequencing for Detection of Bovine Pathogens in Clinical Samples. J Clin Microbiol. 2018;56. [PMID: 29695524 DOI: 10.1128/JCM.00399-18] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
6 Zhang X, Liang Z, Wang S, Lu S, Song Y, Cheng Y, Ying J, Liu W, Hou Y, Li Y, Liu Y, Hou J, Liu X, Shao J, Tai Y, Wang Z, Fu L, Li H, Zhou X, Bai H, Wang M, Lu Y, Yang J, Zhong W, Zhou Q, Yang X, Wang J, Huang C, Liu X, Zhou X, Zhang S, Tian H, Chen Y, Ren R, Liao N, Wu C, Zhu Z, Pan H, Gu Y, Wang L, Liu Y, Zhang S, Liu T, Chen G, Shao Z, Xu B, Zhang Q, Xu R, Shen L, Wu Y, Tumor Biomarker Committee OBOCSOCOC. Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology. Cancer Biol Med 2019;16:189-204. [PMID: 31119060 DOI: 10.20892/j.issn.2095-3941.2018.0142] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
7 Hofman P. Next-Generation Sequencing with Liquid Biopsies from Treatment-Naïve Non-Small Cell Lung Carcinoma Patients. Cancers (Basel) 2021;13:2049. [PMID: 33922637 DOI: 10.3390/cancers13092049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zhao L, Deng L, Li G, Jin H, Cai J, Shang H, Li Y, Wu H, Xu W, Zeng L, Zhang R, Zhao H, Wu P, Zhou Z, Zheng J, Ezanno P, Yang AX, Yan Q, Deem MW, He J. Single molecule sequencing of the M13 virus genome without amplification. PLoS One 2017;12:e0188181. [PMID: 29253901 DOI: 10.1371/journal.pone.0188181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nicora G, Moretti F, Sauta E, Della Porta M, Malcovati L, Cazzola M, Quaglini S, Bellazzi R. A continuous-time Markov model approach for modeling myelodysplastic syndromes progression from cross-sectional data. J Biomed Inform 2020;104:103398. [PMID: 32113003 DOI: 10.1016/j.jbi.2020.103398] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zhu SK. Role of precision medicine in pancreatic cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(36): 4752-4758 [DOI: 10.11569/wcjd.v24.i36.4752] [Reference Citation Analysis]
11 Niklinski J, Kretowski A, Moniuszko M, Reszec J, Michalska-Falkowska A, Niemira M, Ciborowski M, Charkiewicz R, Jurgilewicz D, Kozlowski M, Ramlau R, Piwkowski C, Kwasniewski M, Kaczmarek M, Ciereszko A, Wasniewski T, Mroz R, Naumnik W, Sierko E, Paczkowska M, Kisluk J, Sulewska A, Cybulski A, Mariak Z, Kedra B, Szamatowicz J, Kurzawa P, Minarowski L, Charkiewicz AE, Mroczko B, Malyszko J, Manegold C, Pilz L, Allgayer H, Abba ML, Juhl H, Koch F; MOBIT Study Group. Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project. Adv Med Sci 2017;62:405-13. [PMID: 28646744 DOI: 10.1016/j.advms.2017.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
12 Yoo BC, Kim KH, Woo SM, Myung JK. Clinical multi-omics strategies for the effective cancer management. J Proteomics 2018;188:97-106. [PMID: 28821459 DOI: 10.1016/j.jprot.2017.08.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
13 Horton I, Lin Y, Reed G, Wiepert M, Hart S. Empowering Mayo Clinic Individualized Medicine with Genomic Data Warehousing. J Pers Med 2017;7:E7. [PMID: 28829408 DOI: 10.3390/jpm7030007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sayitoğlu M. Clinical Interpretation of Genomic Variations. Turk J Haematol 2016;33:172-9. [PMID: 27507302 DOI: 10.4274/tjh.2016.0149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
15 Miao Z, Mu T, Liu L, Rao J, Jin M, Wang Z, Wang H, Lu C, Gong X, Zheng D, Zheng D, Li X, Li Y, Chen S, Shu X. Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion. Front Oncol 2020;10:561341. [PMID: 33194628 DOI: 10.3389/fonc.2020.561341] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Ceroni D, Dayer R, Steiger C. Are we approaching the end of pediatric culture-negative osteoarticular infections? Future Microbiology 2019;14:917-9. [DOI: 10.2217/fmb-2019-0141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Strianese O, Rizzo F, Ciccarelli M, Galasso G, D'Agostino Y, Salvati A, Del Giudice C, Tesorio P, Rusciano MR. Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease. Genes (Basel) 2020;11:E747. [PMID: 32640513 DOI: 10.3390/genes11070747] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
18 Pillai S, Gopalan V, Lo CY, Liew V, Smith RA, Lam AK. Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma/paraganglioma: A clinicopathological correlations. Exp Mol Pathol 2017;102:41-6. [PMID: 27986441 DOI: 10.1016/j.yexmp.2016.12.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
19 Dunn T, Berry G, Emig-Agius D, Jiang Y, Lei S, Iyer A, Udar N, Chuang HY, Hegarty J, Dickover M, Klotzle B, Robbins J, Bibikova M, Peeters M, Strömberg M. Pisces: an accurate and versatile variant caller for somatic and germline next-generation sequencing data. Bioinformatics 2019;35:1579-81. [PMID: 30304370 DOI: 10.1093/bioinformatics/bty849] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
20 Zascavage RR, Thorson K, Planz JV. Nanopore sequencing: An enrichment-free alternative to mitochondrial DNA sequencing. Electrophoresis 2019;40:272-80. [PMID: 30511783 DOI: 10.1002/elps.201800083] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
21 Hermann BT, Pfeil S, Groenke N, Schaible S, Kunze R, Ris F, Hagen ME, Bhakdi J. DEEPGENTM-A Novel Variant Calling Assay for Low Frequency Variants. Genes (Basel) 2021;12:507. [PMID: 33808158 DOI: 10.3390/genes12040507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Iacoangeli A, Al Khleifat A, Sproviero W, Shatunov A, Jones AR, Morgan SL, Pittman A, Dobson RJ, Newhouse SJ, Al-Chalabi A. DNAscan: personal computer compatible NGS analysis, annotation and visualisation. BMC Bioinformatics 2019;20:213. [PMID: 31029080 DOI: 10.1186/s12859-019-2791-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Xu Y, Doonan SR, Ordog T, Bailey RC. Translational Opportunities for Microfluidic Technologies to Enable Precision Epigenomics. Anal Chem 2020;92:7989-97. [PMID: 32496751 DOI: 10.1021/acs.analchem.0c01288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Alese OB, Cook N, Ortega-Franco A, Ulanja MB, Tan L, Tie J. Circulating Tumor DNA: An Emerging Tool in Gastrointestinal Cancers. Am Soc Clin Oncol Educ Book 2022;42:1-20. [PMID: 35471832 DOI: 10.1200/EDBK_349143] [Reference Citation Analysis]
25 Loree JM, Kopetz S, Raghav KP. Current companion diagnostics in advanced colorectal cancer; getting a bigger and better piece of the pie. J Gastrointest Oncol 2017;8:199-212. [PMID: 28280626 DOI: 10.21037/jgo.2017.01.01] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
26 Arnold L, Alexiadis V, Watanaskul T, Zarrabi V, Poole J, Singh V. Clinical validation of qPCR Target Selector™ assays using highly specific switch-blockers for rare mutation detection. J Clin Pathol 2020;73:648-55. [PMID: 32132121 DOI: 10.1136/jclinpath-2019-206381] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Bennett CW, Berchem G, Kim YJ, El-Khoury V. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer. Oncotarget 2016;7:71013-35. [PMID: 27589834 DOI: 10.18632/oncotarget.11717] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
28 Loree JM, Kopetz S. Recent developments in the treatment of metastatic colorectal cancer. Ther Adv Med Oncol 2017;9:551-64. [PMID: 28794806 DOI: 10.1177/1758834017714997] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 10.8] [Reference Citation Analysis]
29 Simons MJHG, Retèl VP, Ramaekers BLT, Butter R, Mankor JM, Paats MS, Aerts JGJV, Mfumbilwa ZA, Roepman P, Coupé VMH, Uyl-de Groot CA, van Harten WH, Joore MA. Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer. Pharmacoeconomics 2021. [PMID: 34405371 DOI: 10.1007/s40273-021-01073-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Frisone D, Friedlaender A, Malapelle U, Banna G, Addeo A. A BRAF new world. Crit Rev Oncol Hematol. 2020;152:103008. [PMID: 32485528 DOI: 10.1016/j.critrevonc.2020.103008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
31 Mohapatra SS, Batra SK, Bharadwaj S, Bouvet M, Cosman B, Goel A, Jogunoori W, Kelley MJ, Mishra L, Mishra B, Mohapatra S, Patel B, Pisegna JR, Raufman JP, Rao S, Roy H, Scheuner M, Singh S, Vidyarthi G, White J. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions. Dig Dis Sci 2018;63:1123-38. [PMID: 29572615 DOI: 10.1007/s10620-018-5000-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
32 Ida K, Miyamoto T, Higuchi S, Takeuchi H, Yamada S, Ono M, Nishihara H, Shiozawa T. Effectiveness of a genetic test panel designed for gynecological cancer: an exploratory study. Med Oncol 2019;36. [DOI: 10.1007/s12032-019-1286-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Chinese Society of Clinical Oncology, Expert Committee on Non-small Cell Lung Cancer. [Chinese Expert Consensus on Next Generation Sequencing Diagnosis 
for Non-small Cell Lung Cancer (2020 Edition)]. Zhongguo Fei Ai Za Zhi 2020;23:741-61. [PMID: 32957170 DOI: 10.3779/j.issn.1009-3419.2020.101.45] [Reference Citation Analysis]
34 Chung D, Zhang K, Yang J. Method for Identifying Cancer-Related Genes Using Gene Similarity-Based Collaborative Filtering. J Comput Biol 2019;26:875-81. [PMID: 31120387 DOI: 10.1089/cmb.2018.0115] [Reference Citation Analysis]
35 Pennell NA, Mutebi A, Zhou Z, Ricculli ML, Tang W, Wang H, Guerin A, Arnhart T, Dalal A, Sasane M, Wu KY, Culver KW, Otterson GA. Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non–Small-Cell Lung Cancer Using a Decision Analytic Model. JCO Precision Oncology 2019. [DOI: 10.1200/po.18.00356] [Cited by in Crossref: 12] [Article Influence: 4.0] [Reference Citation Analysis]
36 Rothstein MA. Time to End the Use of Genetic Test Results in Life Insurance Underwriting. J Law Med Ethics 2018;46:794-801. [DOI: 10.1177/1073110518804243] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
37 Ergun MA, Unal A, Ergun SG, Percin E. A new method for analysis of whole exome sequencing data (SELIM) depending on variant prioritization. Informatics in Medicine Unlocked 2017;8:51-3. [DOI: 10.1016/j.imu.2017.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
38 Oliveira DM, Mirante T, Mignogna C, Scrima M, Migliozzi S, Rocco G, Franco R, Corcione F, Viglietto G, Malanga D, Rizzuto A. Simultaneous identification of clinically relevant single nucleotide variants, copy number alterations and gene fusions in solid tumors by targeted next-generation sequencing. Oncotarget 2018;9:22749-68. [PMID: 29854313 DOI: 10.18632/oncotarget.25229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
39 [DOI: 10.1101/783605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Del Vecchio F, Mastroiaco V, Di Marco A, Compagnoni C, Capece D, Zazzeroni F, Capalbo C, Alesse E, Tessitore A. Next-generation sequencing: recent applications to the analysis of colorectal cancer. J Transl Med. 2017;15:246. [PMID: 29221448 DOI: 10.1186/s12967-017-1353-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
41 Harvey MJ, Cunningham R, Sawchyn B, Montesion M, Reddy P, McBride A, Chawla AJ. Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non-Small-Cell Lung Cancer. JCO Precis Oncol 2021;5:1611-24. [PMID: 34994647 DOI: 10.1200/PO.20.00540] [Reference Citation Analysis]
42 Prieto-Potin I, Carvajal N, Plaza-Sánchez J, Manso R, Aúz-Alexandre CL, Chamizo C, Zazo S, López-Sánchez A, Rodríguez-Pinilla SM, Camacho L, Longarón R, Bellosillo B, Somoza R, Hernández-Losa J, Fernández-Soria VM, Ramos-Ruiz R, Cristóbal I, García-Foncillas J, Rojo F. Validation and clinical application of a targeted next-generation sequencing gene panel for solid and hematologic malignancies. PeerJ 2020;8:e10069. [PMID: 33083132 DOI: 10.7717/peerj.10069] [Reference Citation Analysis]
43 Wang Z, Liu X, Ho RL, Lam CW, Chow MS. Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal Medicine. Molecules 2016;21:E889. [PMID: 27399658 DOI: 10.3390/molecules21070889] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
44 Prendergast EN, Elvin JA. Genomic profiling of gynecologic cancers and implications for clinical practice. Curr Opin Obstet Gynecol 2017;29:18-25. [PMID: 27984344 DOI: 10.1097/GCO.0000000000000335] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]